Leczenie biologiczne wrzodziejącego zapalenia jelita grubego u dzieci

Journal Title: Postępy Nauk Medycznych - Year 2014, Vol 27, Issue 3

Abstract

Ulcerative colitis is a chronic inflammatory bowel disease of unknown etiology. Actually, the main pathogenic role is attributed to pro-inflammatory cytokines, the major one is Tumour Necrosis Factor alpha (TNF-α). The advances in understanding the pathogenesis of inflammatory bowel disease have led to the introduction of new therapeutic options, biological agents. Till now U.S. Food and Drug Administration (FDA) approved three monoclonal antibodies against TNF-α to treat adults with moderate to severe ulcerative colitis with an inadequate response to conventional therapy, or who are intolerant, or have medical contraindications for such therapy. These are: infliximab, adalimumab and golimumab. Only infliximab has been approved by the agency to treat children, nonetheless adalimumab is also used in treatment of pediatric patients with ulcerative colitis. The purpose of this review is to summarize the current knowledge on the use of biologics in pediatric ulcerative colitis. Currently, this new therapeutic options are the integral part of the pediatric ulcerative colitis treatment algorithm and with time probably will be used more extensively.

Authors and Affiliations

Anna Wiernicka, Maciej Dądalski, Monika Szychta, Grzegorz Oracz, Jarosław Kierkuś

Keywords

Related Articles

Endovascular treatment of carotid cavernous fistulas

Carotid caveronus fistulas are incorrect connections between carotid arteries and cavernous sinus. Presence of such fistulas results with elevated blood pressure in caveronus sinus and draining vessels. Development of en...

Breast reduction surgery of hypertrophic and sagging breasts in the material from the Plastic Surgery Clinic of the Postgraduate Education Centre in Warsaw

Introduction. Significant breast hypertrophy and ptosis is a medical indication for surgical treatment. Patients seek help because of vertebral diseases, painful bra grooving and inframammary rashes.Aim. The aim of the s...

Cukrzycowa kwasica ketonowa u dzieci – opis trzech przypadków

Cukrzycowa kwasica ketonowa (ang. diabetic ketoacidosis – DKA) jest ostrym powikłaniem metabolicznym cukrzycy typu 1. Wystąpić może w przypadku opóźnionego rozpoznania choroby oraz u chorych z cukrzycą typu 1 w sytuacji...

Zaburzenia oddychania u dzieci chrapiących w czasie snu, w świetle badań polisomnograficznych

<b>Cel pracy.</b> Określenie częstości występowania i charakteru zaburzeń oddychania podczas snu u dzieci chrapiących.<br><b>Materiał i metody.</b> 10...

Obesity – health and global challeng

Obesity is a very serious public health problem in many countries. In Poland more than half of the adults have excessive body weight, while approx. 20% are obese. Overweight and obesity occur among 15-20% of children and...

Download PDF file
  • EP ID EP54936
  • DOI -
  • Views 173
  • Downloads 0

How To Cite

Anna Wiernicka, Maciej Dądalski, Monika Szychta, Grzegorz Oracz, Jarosław Kierkuś (2014). Leczenie biologiczne wrzodziejącego zapalenia jelita grubego u dzieci. Postępy Nauk Medycznych, 27(3), -. https://europub.co.uk/articles/-A-54936